Chief Commercial Ofc Imm Med
Avg Cost/Share
$21.14
Shares
154,768
Total Value
$3,271,795.52
Owned After
221,278
SEC Form 4
Chief Commercial Ofc Imm Med
Avg Cost/Share
$21.00
Shares
11,034
Total Value
$231,714.00
Owned After
221,278
SEC Form 4
Chief Commercial Ofc Imm Med
Avg Cost/Share
$16.91
Shares
308,477
Total Value
$5,216,346.07
Owned After
221,278
SEC Form 4
Chief Commercial Ofc Imm Med
Avg Cost/Share
$16.54
Shares
297,925
Total Value
$4,927,679.50
Owned After
221,278
SEC Form 4
Chief Commercial Ofc Imm Med
Avg Cost/Share
$6.99
Shares
44,665
Total Value
$311,792.35
Owned After
221,278
Chief Commercial Ofc Imm Med
Avg Cost/Share
$3.44
Shares
29,390
Total Value
$100,994.14
Owned After
221,278
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| BENZENO SHARON | ADPT | Chief Commercial Ofc Imm Med | Jun 29, 2026 | Sell | $21.14 | 154,768 | $3,271,795.52 | 221,278 | |
| BENZENO SHARON | ADPT | Chief Commercial Ofc Imm Med | Jun 26, 2026 | Sell | $21.00 | 11,034 | $231,714.00 | 221,278 | |
| BENZENO SHARON | ADPT | Chief Commercial Ofc Imm Med | Nov 21, 2025 | Sell | $16.91 | 308,477 | $5,216,346.07 | 221,278 | |
| BENZENO SHARON | ADPT | Chief Commercial Ofc Imm Med | Nov 20, 2025 | Sell | $16.54 | 297,925 | $4,927,679.50 | 221,278 | |
| BENZENO SHARON | ADPT | Chief Commercial Ofc Imm Med | Mar 4, 2025 | Sell | $6.99 | 44,665 | $311,792.35 | 221,278 | |
| BENZENO SHARON | ADPT | Chief Commercial Ofc Imm Med | Mar 4, 2024 | Sell | $3.44 | 29,390 | $100,994.14 | 221,278 |